Materialise NV, a global leader in 3D-printed medical devices and additive manufacturing software, announced plans to pursue an additional listing of its ordinary shares on Euronext Brussels to complement its existing Nasdaq listing of American depositary shares (ADSs) representing ordinary shares. The listing, expected to occur on or around November 20, 2025, aims to broaden the company's investor base and provide enhanced liquidity options for shareholders. The move will also enable Materialise to initiate potential ADS and/or share buyback programs. KBC Securities serves as the listing agent for the Euronext Brussels listing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Materialise NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-104051), on October 30, 2025, and is solely responsible for the information contained therein.